Plancorp LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $462K | Sell |
880
-17
| -2% | -$8.93K | 0.02% | 235 |
|
|
2025
Q1 | $569K | Sell |
897
-2
| -0.2% | -$1.27K | 0.02% | 190 |
|
|
2024
Q4 | $640K | Sell |
899
-22
| -2% | -$15.7K | 0.03% | 165 |
|
|
2024
Q3 | $968K | Buy |
921
+3
| +0.3% | +$3.15K | 0.04% | 133 |
|
|
2024
Q2 | $965K | Buy |
918
+8
| +0.9% | +$8.41K | 0.04% | 124 |
|
|
2024
Q1 | $876K | Buy |
910
+12
| +1% | +$11.6K | 0.04% | 130 |
|
|
2023
Q4 | $789K | Buy |
898
+20
| +2% | +$17.6K | 0.04% | 125 |
|
|
2023
Q3 | $723K | Buy |
878
+11
| +1% | +$9.05K | 0.04% | 128 |
|
|
2023
Q2 | $623K | Sell |
867
-1
| -0.1% | -$719 | 0.03% | 137 |
|
|
2023
Q1 | $713K | Sell |
868
-34
| -4% | -$27.9K | 0.04% | 129 |
|
|
2022
Q4 | $651K | Buy |
902
+3
| +0.3% | +$2.16K | 0.04% | 129 |
|
|
2022
Q3 | $619K | Buy |
899
+23
| +3% | +$15.8K | 0.04% | 124 |
|
|
2022
Q2 | $518K | Sell |
876
-1,400
| -62% | -$828K | 0.03% | 146 |
|
|
2022
Q1 | $1.59M | Buy |
2,276
+17
| +0.8% | +$11.9K | 0.1% | 81 |
|
|
2021
Q4 | $1.43M | Buy |
2,259
+39
| +2% | +$24.6K | 0.09% | 80 |
|
|
2021
Q3 | $1.34M | Buy |
2,220
+3
| +0.1% | +$1.82K | 0.09% | 76 |
|
|
2021
Q2 | $1.24M | Hold |
2,217
| – | – | 0.1% | 78 |
|
|
2021
Q1 | $1.05M | Hold |
2,217
| – | – | 0.23% | 74 |
|
|
2020
Q4 | $1.07M | Sell |
2,217
-303
| -12% | -$146K | 0.26% | 70 |
|
|
2020
Q3 | $1.41M | Buy |
+2,520
| New | +$1.41M | 0.43% | 46 |
|